Integra LifeSciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $434,925 | $402,062 | $415,605 | $382,653 |
Gross Profit | 215,362 | 226,108 | 209,332 | 194,432 |
EBITDA | 65,988 | 54,063 | -472,218 | 25,967 |
EBIT | 27,983 | 15,901 | -509,910 | -11,221 |
Net Income | -1,704 | -5,404 | -484,073 | -25,293 |
Net Change In Cash | 434,925 | 402,062 | 415,605 | 382,653 |
Free Cash Flow | -37,250 | 25,750 | -11,227 | -40,177 |
Cash | 235,048 | 232,186 | 217,914 | 239,104 |
Basic Shares | 76,753 | 76,753 | 76,463 | 76,463 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,635,245 | $1,610,527 | $1,541,573 | $1,557,666 |
Gross Profit | 845,234 | 882,061 | 884,735 | 970,311 |
EBITDA | -326,200 | 193,288 | 255,958 | 384,603 |
EBIT | -477,247 | 52,788 | 132,446 | 263,488 |
Net Income | -516,474 | -6,944 | 67,741 | 180,550 |
Net Change In Cash | 1,635,245 | 1,610,527 | 1,541,573 | 1,557,666 |
Cost of Revenue | -46,064 | |||
Free Cash Flow | -31,052 | 24,964 | 73,090 | 217,384 |
Cash | 235,048 | 246,375 | 276,402 | 456,661 |
Basic Shares | 76,753 | 77,010 | 80,337 | 83,516 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.83 |
2025-09-30 | $0.54 |
2025-06-30 | $0.45 |
